# The Effects Of Ropinirole On Mood Or Mild Depression In Patients With Moderate To Severe Restless Legs Syndrome

> **NCT00357097** · PHASE3 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 240 (actual)

## Conditions studied

- Restless Legs Syndrome
- Moderate to Severe Idiopathic Restless Legs Syndrome (RLS)

## Interventions

- **DRUG:** Ropinirole

## Key facts

- **NCT ID:** NCT00357097
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-06
- **Primary completion:** 2007-12
- **Final completion:** 2007-12
- **Target enrollment:** 240 (ACTUAL)
- **Last updated:** 2012-06-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00357097

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00357097, "The Effects Of Ropinirole On Mood Or Mild Depression In Patients With Moderate To Severe Restless Legs Syndrome". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00357097. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*